Veterinary Medicines

Parafend 2.265 % Oral Suspension

Authorised
  • Oxfendazole
Download as PDF

Product identification

Medicine name:
Parafend 2.265 % Oral Suspension
Active substance:
  • Oxfendazole
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Oxfendazole
    2.27
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        5
        day
    • Sheep
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Parafend will be presented in 10 L multi-dose polyethylene containers with polyethylene closures.
  • Parafend will be presented in 5 L multi-dose polyethylene containers with polyethylene closures.
  • Parafend will be presented in 2.5 L multi-dose polyethylene containers with polyethylene closures.
  • Parafend will be presented in 1.0 L multi-dose polyethylene containers with polyethylene closures.
  • Parafend will be presented in 500 ml multi-dose polyethylene containers with polyethylene closures.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22664/040/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download